These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 22226021

  • 1. 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer.
    Jackson AB, Nanda PK, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Chen X, Smith CJ.
    Nucl Med Biol; 2012 Apr; 39(3):377-87. PubMed ID: 22226021
    [Abstract] [Full Text] [Related]

  • 2. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Durkan K, Jiang Z, Rold TL, Sieckman GL, Hoffman TJ, Bandari RP, Szczodroski AF, Liu L, Miao Y, Reynolds TS, Smith CJ.
    Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266
    [Abstract] [Full Text] [Related]

  • 3. Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nanda PK, Pandey U, Bottenus BN, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Smith CJ.
    Nucl Med Biol; 2012 May; 39(4):461-71. PubMed ID: 22261143
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP, Jiang Z, Reynolds TS, Bernskoetter NE, Szczodroski AF, Bassuner KJ, Kirkpatrick DL, Rold TL, Sieckman GL, Hoffman TJ, Connors JP, Smith CJ.
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [Abstract] [Full Text] [Related]

  • 5. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
    Lane SR, Nanda P, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Jurisson SS, Smith CJ.
    Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
    [Abstract] [Full Text] [Related]

  • 6. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z, Yan Y, Liu S, Wang F, Chen X.
    Bioconjug Chem; 2009 May 20; 20(5):1016-25. PubMed ID: 20540537
    [Abstract] [Full Text] [Related]

  • 7.
    Shan L.
    ; 2004 May 20. PubMed ID: 21290624
    [Abstract] [Full Text] [Related]

  • 8. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ, Schehr R, Liu D, Xu J, Miao Y, Hoffman TJ, Rold TL, Lewis MR, Smith CJ.
    Nucl Med Biol; 2015 Feb 20; 42(2):99-108. PubMed ID: 25459113
    [Abstract] [Full Text] [Related]

  • 9.
    Shan L.
    ; 2004 Feb 20. PubMed ID: 21290623
    [Abstract] [Full Text] [Related]

  • 10.
    Shan L.
    ; 2004 Feb 20. PubMed ID: 21290625
    [Abstract] [Full Text] [Related]

  • 11.
    Leung K.
    ; 2004 Feb 20. PubMed ID: 23166957
    [Abstract] [Full Text] [Related]

  • 12. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.
    Liu Z, Niu G, Wang F, Chen X.
    Eur J Nucl Med Mol Imaging; 2009 Sep 20; 36(9):1483-94. PubMed ID: 19360404
    [Abstract] [Full Text] [Related]

  • 13. Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
    Bandara N, Stott Reynolds TJ, Schehr R, Bandari RP, Diebolder PJ, Krieger S, Xu J, Miao Y, Rogers BE, Smith CJ.
    Nucl Med Biol; 2018 Sep 20; 62-63():71-77. PubMed ID: 29929115
    [Abstract] [Full Text] [Related]

  • 14. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y.
    Amino Acids; 2014 Jun 20; 46(6):1481-9. PubMed ID: 24633452
    [Abstract] [Full Text] [Related]

  • 15. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
    Liu Z, Li ZB, Cao Q, Liu S, Wang F, Chen X.
    J Nucl Med; 2009 Jul 20; 50(7):1168-77. PubMed ID: 19525469
    [Abstract] [Full Text] [Related]

  • 16. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.
    Prasanphanich AF, Nanda PK, Rold TL, Ma L, Lewis MR, Garrison JC, Hoffman TJ, Sieckman GL, Figueroa SD, Smith CJ.
    Proc Natl Acad Sci U S A; 2007 Jul 24; 104(30):12462-7. PubMed ID: 17626788
    [Abstract] [Full Text] [Related]

  • 17. Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer.
    Lucente E, Liu H, Liu Y, Hu X, Lacivita E, Leopoldo M, Cheng Z.
    Bioconjug Chem; 2018 May 16; 29(5):1595-1604. PubMed ID: 29587479
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z, Aberg O, Velikyan I, Lindeberg G, Sörensen J, Larhed M, Antoni G, Sandström M, Tolmachev V, Orlova A.
    PLoS One; 2013 May 16; 8(12):e81932. PubMed ID: 24312607
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors.
    Prasanphanich AF, Retzloff L, Lane SR, Nanda PK, Sieckman GL, Rold TL, Ma L, Figueroa SD, Sublett SV, Hoffman TJ, Smith CJ.
    Nucl Med Biol; 2009 Feb 16; 36(2):171-81. PubMed ID: 19217529
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.
    Craft JM, De Silva RA, Lears KA, Andrews R, Liang K, Achilefu S, Rogers BE.
    Nucl Med Biol; 2012 Jul 16; 39(5):609-16. PubMed ID: 22261146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.